Alexander Varvak

USPTO Granted Patents = 8 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

San Diego, CA (US) (2008 - 2015)
Netanya, IL (2015 - 2016)

Company Filing History:

Bp Corporation North America Inc.

Years Active: 2008-2016

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9234216 - Variant CBH I polypeptides (2016-01-12),

2. 9150845 - Lyase enzymes, nucleic acids encoding them and methods for making and using them (2015-10-06),

3. RE45660 - Xylanases, nucleic acids encoding them and methods for making and using them (2015-08-31),

4. 9096871 - Variant CBH I polypeptides with reduced product inhibition (2015-08-04),

5. 8735107 - Lyase enzymes, nucleic acids encoding them and methods for making and using them (2014-05-27),

6. 8148324 - Chemoenzymatic methods for the synthesis of statins and statin intermediates (2012-04-03),

7. 8043839 - Xylanases, nucleic acids encoding them and methods for making and using them (2011-10-25),

8. 7414119 - Aldolases, nucleic acids encoding them and methods for making and using them (2008-08-19),

Title: Alexander Varvak: Innovator in Polypeptide Technology

Introduction

Alexander Varvak is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of biotechnology. With a total of 8 patents, Varvak has focused on developing innovative polypeptides with various applications in pharmaceuticals, agriculture, and industrial processes.

Latest Patents

Among his latest patents, Varvak has developed polypeptides with lignocellulolytic activity. These polypeptides include glycosyl hydrolases, cellulases, and other enzymes that facilitate the bioconversion of biomass into fermentable sugars. This technology is particularly relevant for producing biofuels such as ethanol and methanol. Additionally, he has patented lyase enzymes, including phenylalanine ammonia lyase and tyrosine ammonia lyase, which also have applications in various industrial contexts.

Career Highlights

Varvak has worked with notable companies such as Verenium Corporation and BP Corporation North America Inc. His work has significantly advanced the understanding and application of polypeptides in bioconversion processes. His innovative approaches have positioned him as a key figure in the biotechnology sector.

Collaborations

Throughout his career, Varvak has collaborated with esteemed colleagues, including Shaun Healey and David Paul Weiner. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in polypeptide technology.

Conclusion

Alexander Varvak's contributions to biotechnology through his innovative patents and collaborations have made a lasting impact on the industry. His work continues to influence the development of sustainable solutions in various fields.

This text is generated by artificial intelligence and may not be accurate.